BMJ  2008;336:686 (29 March), doi:10.1136/bmj.39526.738345.DB

News

Drug industry anxious about scrapping price regulation scheme

Andrew Cole

1 London

The first 150 words of the full text of this article appear below.

Almost half (46%) of the United Kingdom’s drug companies expect to cut back on clinical trials in the coming year because of continued uncertainty about future arrangements for pricing drugs.

In a survey of more than 100 companies earlier this month on behalf of the Association of the British Pharmaceutical Industry and the Confederation of British Industry three quarters said they had little confidence in the current UK market environment, and 83% expected things to get worse in the next year.

The survey also showed that 30% of drug companies expect to cut staff in the next year, and more than a third expect to reduce research and development and investment in buildings and equipment. Two in five anticipated cutting back on manufacturing in the UK.

Despite this, almost two thirds thought their own business would grow in the coming year, and 43% thought their performance would improve. But nearly . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Article

Of medicine and medicines
Tony Delamothe
BMJ 2008 336: 0. [Extract] [Full Text]

Access all current jobs at BMJ Group
Whats new online at Student BMJ
Listen to the latest BMJ Interview